Collateral damage: the conundrum of drug safety.
Gale
E A M
EA
D003695:Delivery of Health Care / Q000191:economics; D003920:Diabetes Mellitus / Q000188:drug therapy*; D064420:Drug-Related Side Effects and Adverse Reactions / Q000191:economics*; D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects / Q000191:economics*
D007004:Hypoglycemic Agents
Diabetologia. 2009 Jan;52(1):17-30
18941734
Health Aff (Millwood). 2005 Jul-Aug;24(4):938-48
16012136
N Engl J Med. 2007 Feb 1;356(5):437-40
17267901
Diabetologia. 2006 Jan;49(1):1-6
16362281
JAMA. 1998 May 20;279(19):1571-3
9605903
Diabetologia. 2009 Sep;52(9):1778-88
19526210
N Engl J Med. 2007 Jun 14;356(24):2457-71
17517853
Curr Med Res Opin. 2009 Apr;25(4):1019-27
19278373
BMJ. 2004 Jul 3;329(7456):44-7
15231627
Diabetes Care. 2006 Feb;29(2):471
16443920
J Med Ethics. 2009 Feb;35(2):107-12
19181884
Expert Opin Drug Saf. 2007 Jul;6(4):417-22
17688385
Diabetes Care. 2007 Dec;30(12):2989-92
17804681
N Engl J Med. 2008 May 1;358(18):1969-70; discussion 1971-2
18450614
Diabetologia. 2006 Feb;49(2):247-52
16416145
Lancet. 2000 Jan 1;355(9197):61-3
10615905
QJM. 2004 Jul;97(7):439-49
15208432
Expert Opin Drug Saf. 2008 Nov;7(6):643-4
18983211
Diabetes Care. 2009 May;32(5):834-8
19208917
Diabetologia. 2009 Sep;52(9):1699-708
19597799
J Assoc Physicians India. 2008 Dec;56:987-8
19322980